Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Evolus Expands Partnership with Symatese to Commercialize HA Gels in Canada, Australia, and New Zealand.
Aug 04, 2026
Contract Type
partnership
Newport BeachHealthcareHealth CareFitnessWellness
Description
Evolus Inc. announced the expansion of its partnership with Symatese to market the Estyme collection of injectable hyaluronic acid gels in Canada, Australia, and New Zealand. This follows their earlier agreement in 2023, which provided Evolus with exclusive U.S. distribution rights for a portfolio of dermal fillers.
Company Information
Company
Evolus
Location
520 Newport Center Drive
Newport Beach, California, United States
About
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. Approved in 2019 by the U.S. Food and Drug Administration, Jeuveau® (prabotulinumtoxinA-xvfs) is the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus’ unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today.